| Shannon Welter, MD | |
|
6401 France Ave S, Edina, MN 55435-2104 | |
| (952) 924-5000 | |
| Not Available |
| Full Name | Shannon Welter |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 15 Years |
| Location | 6401 France Ave S, Edina, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386873958 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairview Southdale Hospital | Edina, MN | Hospital |
| Fairview Ridges Hospital | Burnsville, MN | Hospital |
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Welter, MD 820 Brockton Ln N, Plymouth, MN 55447-3343 Ph: (612) 720-8885 | Shannon Welter, MD 6401 France Ave S, Edina, MN 55435-2104 Ph: (952) 924-5000 |
News Archive
Emergent BioSolutions Inc. today announced that, in response to solicitation RFP-2011-N-13414, it has received an award to supply the U.S. government with 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) over a period of five years for a total value of up to $1.25 billion.
In a study appearing in the April 26 issue of JAMA, Elizabeth A. Rafferty, M.D., formerly of Massachusetts General Hospital, Boston, and colleagues evaluated the screening performance of digital mammography combined with tomosynthesis (a type of imaging) compared with digital mammography alone for women with varying levels of breast density.
Black scientists are significantly less likely than white scientists to win grants from the National Institutes of Health, according to an audit released Thursday. This confirmed suspicions inside the agency about a lingering bias against African-Americans.
Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.
› Verified 5 days ago
Dr. Randolph K. Peterson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6525 France Ave S, Suite 200, Edina, MN 55435 Phone: 952-927-6501 Fax: 952-653-1435 | |
Kathrine P. Frey, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6401 France Ave S, Edina, MN 55435 Phone: 952-924-5000 | |
Bruce C. Trautman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6401 France Ave S, Edina, MN 55435 Phone: 952-924-5000 | |
Gary J. Carlson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6401 France Ave S, Edina, MN 55435 Phone: 952-924-5000 | |
Daniel Berntson, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6401 France Ave S, Edina, MN 55435 Phone: 952-924-5000 | |
Dale C. Snover, MD Pathology Medicare: Medicare Enrolled Practice Location: 6401 France Ave S, Edina, MN 55435 Phone: 952-924-5000 |